-
A high-protein diet lowers the blood glucose postprandially in persons with type 2 diabetes and improves overall glucose control. However, longer-term studies are necessary to determine the total magnitude of response, possible adverse effects, and long-term acceptability of the diet.
-
The frequency with which patients are hospitalized for atrial fibrillation is increasing dramatically with a large proportion of the increase due to an increased number of elderly patients in the population.
-
The FDA has approved the first 91-day oral contraceptive. The product is taken for 12 weeks (84 days), followed by 1 week of inactive tablets, resulting in 1 menstrual period every 3 months.
-
Weight Loss in Type 2 Diabetes; Dalteparin and Chronic Foot Ulcers in Diabetics with PAD; Pioglitazone and LDL in Nondiabetic Hypertensives
-
Helical CT scan is a definitive way to rule out significant pulmonary embolism.
-
This review article sums up the symptoms and treatment of chronic constipation.
-
Most postmenopausal women who suffer a fracture do not receive treatment for osteoporosis.
-
The FDA has approved the first drug for the treatment of moderate-to-severe Alzheimers disease. Memantine, a noncompetitive inhibitor of the N-methyl-D-aspartate receptor, has been available outside of the United States since 1982.
-
Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis; Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis; Exercise Testing to Predict Cardiovascular and All-Cause Death in Women
-
Exercise reduces the risk of breast cancer after menopause. Although the exercise need not be strenuous, longer duration of exercise confers greater benefit.
